SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-005470
Filing Date
2008-08-08
Accepted
2008-08-08 14:32:58
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 PENWEST PHARMACEUTICALS, CO. b71198pwe10vq.htm 10-Q 375375
2 EX-10.1 2005 STOCK INCENTIVE PLAN, AS AMENDED b71198pwexv10w1.htm EX-10.1 50355
3 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO b71198pwexv31w1.htm EX-31.1 8115
4 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO b71198pwexv31w2.htm EX-31.2 8435
5 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO b71198pwexv32w1.htm EX-32.1 2893
6 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO b71198pwexv32w2.htm EX-32.2 3005
  Complete submission text file 0000950135-08-005470.txt   449622
Mailing Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120
Business Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120 877-736-9378
PENWEST PHARMACEUTICALS CO (Filer) CIK: 0001047188 (see all company filings)

IRS No.: 911513032 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23467 | Film No.: 081001927
SIC: 2834 Pharmaceutical Preparations